Assertio Therapeutics, Inc

ASRT

Assertio Therapeutics, Inc
$4.29 $0.03 0.7%
BATS BZX Real Time Price as of April 18, 2019, 4:30 p.m. View Interactive ASRT Charts

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

News & Analysis: Assertio Therapeutics, Inc

The Fool has written over 100 articles on Assertio Therapeutics, Inc.

All

Market Moves

Earnings








Why Depomed Inc. Stock Spiked Today

The drugmaker is reportedly drawing buyout interest from KKR & Co., upping the possibility that a sale is finally imminent.




Interactive Chart